CyberHeart, a startup that is developing the first non-invasive robotic ablation treatment for cardiac arrhythmias, has recently signed an agreement with the National Cancer Center (NCC) in Tokyo to install the CyberHeart system. This makes NCC the world’s first center to non-invasively treat patients with cardiac radiosurgery.
“We are excited to offer our patients the most advanced, painless and non-invasive treatment for cardiovascular conditions, and thrilled to be the first center in Asia to offer the use of this breakthrough technology,” said Jun Itami, MD, PhD, and chair of the Department of Radiation Oncology, National Cancer Center. “The CyberHeart system allows patients to undergo ablation for cardiac arrhythmias and other vascular conditions as an outpatient. The personalized nature of the ablation allows the treatment to be tailored to the patient’s individual anatomy.”
The National Cancer Center was established in 1962 by the Japanese government as the first national hospital and research institute specializing in cancer patient management. The center offers state-of-the-art therapy in radiosurgery and a world-class R&D capability.
The agreement marks CyberHeart’s initial international activity as word spreads and more physicians seek to embrace its technology to benefit patients. The company has also been in discussions with The Harley Street Clinic, one of the most prestigious and well-respected private hospitals in London, and the Hermitage Clinic in Dublin to begin initial cardiac treatments.
The startup is also making great strides here in the U.S., adding the Texas Heart Institute as a clinical partner. In addition, CyberHeart is giving a poster presentation at ASTRO’s 58th Annual Meeting, the world’s most important gathering for the radiation oncology community attracting 11,000 clinicians.
Lastly, CyberHeart and the Fogarty Institute would like to congratulate former intern Nik Bhatt and Dr. Tom Fogarty for their combined effort in winning the Investigational Cardiac Radiosurgery publishing competition, with their article on the cost-effectiveness of cardiac radiosurgery for atrial fibrillation. Dr. Fogarty is the co-founder of CyberHeart.